Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas

A POLA network study

  • Seyve, Antoine
  • Dehais, Caroline
  • Chinot, Olivier
  • Djelad, Apolline
  • Cohen-Moyal, Elisabeth
  • Bronnimann, Charlotte
  • Gourmelon, Carole
  • Emery, Evelyne
  • Colin, Philippe
  • Boone, Mathieu
  • Vauléon, Elodie
  • Langlois, Olivier
  • di Stefano, Anna-Luisa
  • Seizeur, Romuald
  • Ghiringhelli, François
  • D’Hombres, Anne
  • Feuvret, Loic
  • Guyotat, Jacques
  • Capelle, Laurent
  • Carpentier, Catherine
  • Garnier, Louis
  • Honnorat, Jérôme
  • Meyronet, David
  • Mokhtari, Karima
  • Figarella-Branger, Dominique
  • Ducray, François

  • Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    Department of Neurology 2-Mazarin, APHP, University Hospital Pitié Salpêtrière-Charles Foix, Paris, France

    Department of Neuro-Oncology, AP-HM, University Hospital Timone, Marseille, France

    Department of Neurosurgery, University Hospital of Lille, Lille, France

    Department of Radiotherapy, Claudius Regaud Institut, Cancer University Institut of Toulouse, Oncopole 1, Paul Sabatier University, Toulouse III, Toulouse, France

    Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France

    Department of Medical Oncology, West Cancerology Institut René Gauducheau, Saint-Herblain, France

    Department of Neurosurgery, Caen University Hospital, Caen, France

    Department of Radiotherapy, Courlancy Institut of Cancer, Rouen, France

    Medical Oncology Department, Amiens University Hospital, Amiens, France

    Medical Oncology, Centre Eugène Marquis, Rennes, France

    Department of Neurosurgery, University Hospital of Rouen, Rouen, France

    Neurology Department, Hôpital Foch, Suresnes, France

    Neurosurgery Department, Hôpital de la cavale blanche, CHU Brest, Brest, France

    Medical Oncology, Centre Georges-François Leclerc, Dijon, France

    Department of Radiotherapy, South Group Hospital, Hospices Civils de Lyon, Lyon, France

    Department of Radiotherapy, APHP, University Hospital Pitié Salpêtrière-Charles Foix, Paris, France

    Department of Neurosurgery, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    Department of Neurosurgery, APHP, University Hospital Pitié Salpêtrière-Charles Foix, Paris, France

    Department of Neurology 2-Mazarin, National Institute of Health and Medical Research (Inserm), CNRS, Brain and Spinal Cord Institute, University Hospital Pitié Salpêtrière-Charles Foix, Sorbonne University, Paris, France

    Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    SynatAc Team, Institute NeuroMyoGène, MeLis INSERM U1314/CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France

    Pathology Department, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    Centre de recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR 5286, Cancer Cell Plasticity Department, Transcriptome Diversity in Stem Cells Laboratory, Lyon, France

    Pathology Department, APHP, University Hospital Pitié Salpêtrière-Charles Foix, Paris, France

    APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d’Anatomie Pathologique et de Neuropathologie, Aix-Marseille University, Marseille, France

    Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon, France

    Centre de recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR 5286, Cancer Cell Plasticity Department, Transcriptome Diversity in Stem Cells Laboratory, Lyon, France

Corresponding Authors: François Ducray, MD, PhD, Department of Neuro-Oncology, Hospices Civils de Lyon, 59 Boulevard Pinel, 69677 Bron, France([email protected])

Antoine Seyve, MD, MSc, Department of Neuro-Oncology, Hospices Civils de Lyon, 59 Boulevard Pinel, 69677 Bron, France ([email protected]).

Revised September 17, 2022

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Neuro-Oncology 25(3):p 495-507, March 2023. | DOI: 10.1093/neuonc/noac194
Copyright © Copyright Oxford University Press 2023.